Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Leiden University | OTHER |
| Carlsberg Foundation | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
In this study, we want to continuously record the interaction of 50 stroke survivors with their smartphones during the first 3 months after discharge. The linkage of smart phone use to function and quality of life will be assessed with standardized outcome measures at defined time points.
People with stroke are among the most relevant target groups for unobtrusive monitoring. Worldwide, stroke is the second most frequent cause for lasting disability and causes a substantial burden for the individual, caregivers and society. Thanks to improved treatment, many stroke survivors can be discharged to their homes. However, many have to live with disabilities and are prone to declining function, cognitive impairment and depression. With the acquired data, we want to create a database where digital behavior is analyzed with advanced computational methods. In collaboration with the Department of Cognitive Psychology, University of Leiden, Netherlands, these data will be used to discover specific features for different health issues and to develop tools for the early detection of functional decline for different populations.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention or exposure | Other | No intervention or exposure |
| Measure | Description | Time Frame |
|---|---|---|
| Different parameters of digital behavior | Number of interactions with the smart phone, tapping speed, typing speed, social media use | Continuously throughout the 90 days of monitoring |
| Measure | Description | Time Frame |
|---|---|---|
| EQ5D | Health related quality of life, 5 point subscale, Index values of 0-1 (better), EQ5D VAS 0-100 (better) | Once a week during 12 weeks |
| Mini MoCA | Montreal Cognitive Assessment, cognitive function, scale 0-15 (better) |
| Measure | Description | Time Frame |
|---|---|---|
| Health today | One question about subjective health, VAS 0-100 (better) | Every day throughout 90 days |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
We want to include a broad range of patients with stroke, incuding both ischemic and hemorrhagic strokes and different impairments due to stroke. Patients are recruited at two wards specialized in neurorehabilitation around 1 week before discharge to their home.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Iris Brunner, PhD | Contact | +4560568195 | Iris.Brunner@rm.dk | |
| Jørgen Feldbæk Nielsen, PhD | Contact |
| Name | Affiliation | Role |
|---|---|---|
| Iris C. Brunner, PhD | Aarhus University, Hammel Neurocenter | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hammel Neurorehabilitation Centre and University Research Clinic | Recruiting | Hammel | Aarhus | 8450 | Denmark |
Processed smartphone behavioral data and the associated processing codes will be made available upon publication and corresponding release in data repositories.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 times in three months, after 4, 8 and 12 weeks |
| SF-36 | Health related quality of life, 0-100 (better) | 3 times in three months, after 4, 8 and 12 weeks |
| Stroke Specific Quality of Life Questionnaire - short version | Stroke related quality of life, 12-60 (better) | 3 times in three months, after 4, 8 and 12 weeks |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |